Core Laboratories Inc. (CLB)
NYSE: CLB · Real-Time Price · USD
16.85
-0.78 (-4.42%)
Dec 20, 2024, 4:00 PM EST - Market closed
Core Laboratories Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Core Laboratories stock have an average target of 17, with a low estimate of 14 and a high estimate of 22. The average target predicts an increase of 0.89% from the current stock price of 16.85.
Analyst Consensus: Sell
* Price targets were last updated on Oct 31, 2024.
Analyst Ratings
The average analyst rating for CLB stock from 4 stock analysts is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.
Recommendation Trends
Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 2 | 2 | 2 | 2 | 2 |
Sell | 1 | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Citigroup | Citigroup | Strong Sell Maintains $15 → $14 | Strong Sell | Maintains | $15 → $14 | -16.91% | Oct 31, 2024 |
Stifel | Stifel | Hold Maintains $18 → $22 | Hold | Maintains | $18 → $22 | +30.56% | Jul 26, 2024 |
B of A Securities | B of A Securities | Sell Maintains $16 → $15 | Sell | Maintains | $16 → $15 | -10.98% | Jul 15, 2024 |
Piper Sandler | Piper Sandler | Hold Maintains $18 → $17 | Hold | Maintains | $18 → $17 | +0.89% | Jul 15, 2024 |
Stifel | Stifel | Hold Maintains $17 → $18 | Hold | Maintains | $17 → $18 | +6.82% | Apr 26, 2024 |
Financial Forecast
Revenue This Year
533.95M
from 509.79M
Increased by 4.74%
Revenue Next Year
563.95M
from 533.95M
Increased by 5.62%
EPS This Year
0.86
from 0.77
Increased by 11.14%
EPS Next Year
0.97
from 0.86
Increased by 13.06%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | 558.0M | 608.5M | 609.5M | |||
Avg | 534.0M | 564.0M | 575.9M | |||
Low | 515.0M | 531.8M | 548.7M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | 9.5% | 14.0% | 8.1% | |||
Avg | 4.7% | 5.6% | 2.1% | |||
Low | 1.0% | -0.4% | -2.7% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | 0.95 | 1.13 | 1.30 | |||
Avg | 0.86 | 0.97 | 1.10 | |||
Low | 0.75 | 0.80 | 0.93 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | 23.0% | 32.3% | 33.9% | |||
Avg | 11.1% | 13.1% | 13.5% | |||
Low | -2.0% | -6.1% | -3.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.